# Shruti Agrawal

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/shruti-agrawal/

## Facts

| Field | Value |
| --- | --- |
| Citations | 10,433 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 14 |
| i10-index | 17 |
| Last Known Institution | Bristol-Myers Squibb (Germany) |
| OpenAlex ID | https://openalex.org/A5032222246 |
| ORCID iD | 0000-0002-3859-599X |
| Works | 63 |

## Researcher papers

- [Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer](https://scholariq.org/papers/safety-and-activity-of-anti-pd-l1-antibody-in-patients-with-advanced-cancer/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Researcher university

- [Bristol-Myers Squibb (Germany)](https://scholariq.org/institutions/bristol-myers-squibb-germany/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.